Norges Bank’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-415,776
| Closed | -$31.3M | – | 2159 |
|
|
2022
Q2 | $31.3M | Buy |
415,776
+46,993
| +13% | +$3.54M | 0.01% | 1010 |
|
|
2022
Q1 | $9.9M | Buy |
368,783
+34,000
| +10% | +$913K | ﹤0.01% | 1705 |
|
|
2021
Q4 | $16M | Hold |
334,783
| – | – | ﹤0.01% | 1579 |
|
|
2021
Q3 | $22.2M | Sell |
334,783
-6,171
| -2% | -$410K | ﹤0.01% | 1424 |
|
|
2021
Q2 | $26.6M | Buy |
340,954
+8,624
| +3% | +$673K | 0.01% | 1361 |
|
|
2021
Q1 | $31.4M | Sell |
332,330
-65,388
| -16% | -$6.19M | 0.01% | 1270 |
|
|
2020
Q4 | $48.5M | Buy |
397,718
+63,982
| +19% | +$7.8M | 0.01% | 990 |
|
|
2020
Q3 | $29.2M | Buy |
333,736
+52,595
| +19% | +$4.59M | 0.01% | 1177 |
|
|
2020
Q2 | $18.2M | Buy |
281,141
+22,201
| +9% | +$1.43M | 0.01% | 1493 |
|
|
2020
Q1 | $11.6M | Buy |
+258,940
| New | +$11.6M | ﹤0.01% | 1551 |
|